Roche's digital health venture boosted by pandemic

The covid-19 pandemic has not led to any major shifts in the digital health strategy at Roche, but it has amped up the projects that are already in the works, according to the man in charge.

Roche Global Head of Personalized Healthcare James Musick | Photo: Roche / PR

Lockdowns and self-isolation have led to a lot of attention being given to digital health during the covid-19 pandemic.

This has not gone unnoticed by Roche, which is working on a series of projects in digital health ranging from apps to wearables, which can help home monitoring and remote diagnostics processes.

Read the whole article

Get 14 days free access.
No credit card required.

An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Lundbeck chairman demands change: "We can't live with this"

Years of work developing new treatments at Lundbeck has so far come to nothing. This has led chairman Lars Rasmusssen to demand visible results, even though CEO Deborah Dunsire has essentially had to restart development work since she joined the firm in 2018.

Eli Lilly upgrades earnings per share guidance

On Tuesday, US-based pharmaceutical firm Eli Lilly has updated elements of its 2021 financial guidance pertaining to earnings per share (non-GAAP), now expecting USD 7.95-8.05 compared to the previous USD 7.8-8.

Further reading

Related articles

Trial banner

Latest news

See all jobs